We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPWR
1676
DELISTED
Empowerment & Inclusion Capital I Corp.
EPWR
| $967K | ﹤0.01% |
+99,992
| New | +$976K |
|
|
HCCC
1677
DELISTED
Healthcare Capital Corp. Class A common stock
HCCC
| $966K | ﹤0.01% |
+99,990
| New | +$974K |
|
|
CSOD
1678
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $966K | ﹤0.01% |
22,175
+8,406
| +61% | +$387K |
|
1679
ZTO Express
ZTO
$18.3B
| $964K | ﹤0.01% |
33,067
+2,640
| +9% | +$86.2K |
|
1680
Jefferies Financial Group
JEF
$12.7B
| $963K | ﹤0.01% |
+33,469
| New | +$913K |
|
|
KALV
1681
DELISTED
KalVista Pharmaceuticals
KALV
| $962K | ﹤0.01% |
+37,443
| New | +$984K |
|
1682
Academy Sports + Outdoors
ASO
$3.07B
| $960K | ﹤0.01% |
35,579
-152,547
| -81% | -$3.65M |
|
1683
PUT
Procter & Gamble
PG
$338B
| $948K | ﹤0.01% |
+7,000
| New | +$913K |
|
1684
Oppenheimer Holdings
OPY
$1.17B
| $945K | ﹤0.01% |
23,606
+9,979
| +73% | +$370K |
|
|
AGS
1685
DELISTED
PlayAGS
AGS
| $943K | ﹤0.01% |
116,663
+77,014
| +194% | +$548K |
|
1686
Trinity Capital Inc.
TRIN
$1.59B
| $940K | ﹤0.01% |
+62,974
| New | +$932K |
|
1687
Enterprise Products Partners
EPD
$84.4B
| $936K | ﹤0.01% |
+42,515
| New | +$935K |
|
1688
HF Sinclair
DINO
$16.3B
| $934K | ﹤0.01% |
26,101
-77,006
| -75% | -$2.57M |
|
1689
Aclaris Therapeutics
ACRS
$722M
| $923K | ﹤0.01% |
+36,612
| New | +$716K |
|
1690
Wynn Resorts
WYNN
$10.1B
| $923K | ﹤0.01% |
7,361
-113,164
| -94% | -$13.6M |
|
1691
Federal Signal
FSS
$6.86B
| $921K | ﹤0.01% |
+24,049
| New | +$870K |
|
1692
TransDigm Group
TDG
$71.5B
| $921K | ﹤0.01% |
1,566
-2,769
| -64% | -$1.63M |
|
1693
Otis Worldwide
OTIS
$27.8B
| $920K | ﹤0.01% |
13,442
-323,669
| -96% | -$21.2M |
|
|
AMED
1694
DELISTED
Amedisys
AMED
| $919K | ﹤0.01% |
3,469
-11,656
| -77% | -$3.29M |
|
1695
AppFolio
APPF
$6.68B
| $918K | ﹤0.01% |
+6,494
| New | +$1.01M |
|
1696
International Paper
IP
$22.8B
| $917K | ﹤0.01% |
17,906
-4,569
| -20% | -$222K |
|
1697
Canadian Natural Resources
CNQ
$96.3B
| $916K | ﹤0.01% |
60,515
-7,075
| -10% | -$95.7K |
|
1698
CALL
AEye Inc Warrant
LIDRW
$323K
| $916K | ﹤0.01% |
+91,634
| New | +$206K |
|
|
GRTS
1699
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $915K | ﹤0.01% |
+97,051
| New | +$1.34M |
|
1700
PAVmed
PAVM
$37.3M
| $914K | ﹤0.01% |
+458
| New | +$689K |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.